In-Vitro Diagnostics Business Updates Service - ResearchAndMarkets.com

2024-02-08

并购

DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics Business Outlook, 2024 (6 updates)" report has been added to ResearchAndMarkets.com's offering.

'In Vitro Diagnostics Business Outlook, 2024 (6 updates)'

In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.

In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:

Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities

A comprehensive view of the IVD market with test categories covered and company briefs

M&A activities, selected partnerships & collaborations, partnership deals, and more

Industry & region watch to help tailor strategies

Analysis of news and events and reporting on news not easily available

Key Topics Covered: Sample

Market Analysis: Molecular HLA/Transplant Testing

Overview of Molecular HLA/Transplant Testing

Market Outlook

Regional Market

Top Company Briefs

Immucor

Luminex/Diasorin

Caredx

Thermo Fisher Scientific

Executive News Briefing

Dekfi Diagnostics Appoint New CEO

Onera Raises $32 Million in Funding

Cleveland Diagnostics Completes $75 Million in Funding

Financial Highlights: Agilent and Hologic

Agilent Full Year Fiscal 2023 Sales Up 1.5% in Core Business YOY

Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2022 and Fy 2023

Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2023 Quarterly Performance

Table: Agilent Revenue Mix, by Type (Consumables/Services/Informatics and Instruments), Fy 2023 (%)

Figure: Agilent Fy 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia-Pacific, Europe) (%)

Hologic Supports Strong Financial Performance in Full-Year Fiscal Year Guidance

Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), Fy 2023 ($ Millions)

Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), Fy 2022 and Fy 2023 ($ Millions)

Figure: Hologic Geographic Revenue Distribution, by Region (Asia-Pacific, Europe, United States, All Others), Fy 2023 (%)

Diagnostic Market Mergers, Acquisitions, and Partnership Deals

Mergers and Acquisitions

Table: Selected Diagnostic Market Mergers and Acquisitions Deals

Partnerships and Collaborations

Industry Watch

COVID-19 Update

Region Watch

India

Figure: India Real GDP Growth, Inflation Rate (Consumer Prices), 2017-2024

Figure: India Ivd Market Distribution of Sales, by Broad Ivd Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-Of-Care Glucose, Other Segments), 2023 (%)

Saudi Arabia

Figure: Saudi Arabia Population Pyramid, 2023 and 2053

Figure: Saudi Arabia Total Annual Liquid Fuels Production and Consumption, 2013-2022 (Millions of Barrels)

Figure: Saudi Arabia Ivd Market Share, by Broad Ivd Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-Of-Care Glucose, Other Segments), 2023

Broad-based Company Announcements

Quidelortho Obtains FDA Nod

Illumina Plans to Divest Grail

Roche to Acquire Lumiradx

Qiagen Expands Footprint with New Regional Headquarters in Middle East

For more information about this report visit https://www.researchandmarkets.com/r/dukhdc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构

In Vitro Diagnostics